Blueprint Medicines Corpo...

NASDAQ: BPMC · Real-Time Price · USD
129.46
0.18 (0.14%)
At close: Jul 17, 2025, 3:59 PM

Blueprint Medicines Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-155.73M -67.09M -128.05M -205.49M -288.29M -506.99M -554.71M -554.16M -581.08M -557.52M -717.56M -701.63M -650.37M -644.09M -411.07M 340.15M 325.12M
Depreciation & Amortization
12.61M 16.29M 13.82M 12.83M 12.79M 11.66M 17.15M 15.9M 13.79M 11.73M 6.38M 6.38M 6.5M 6.48M 6.49M 6.52M 6.6M
Stock-Based Compensation
113.74M 108.91M 103.11M 97.9M 93.7M 92.67M 96.2M 97.24M 98.77M 98.97M 95.54M 95.39M 94.34M 91.63M 88.45M 84.13M 79.35M
Other Working Capital
-2.54M -31.41M -15.78M -6.31M -17.49M -17.97M -41.88M -46.57M -19.31M -40.6M -5.32M -20.83M -31.34M 2.8M -20.63M 4.43M -687K
Other Non-Cash Items
-94.69M -137.84M -109.83M -93.02M -87.1M 47.34M 31.4M 2.79M 1.59M -1.7M 250.19M 269.87M 270.43M 269.64M 8.95M 7.55M 6.89M
Deferred Income Tax
n/a n/a -28.89M -40.41M -40.41M -40.41M -11.53M n/a n/a n/a 1.36M 1.36M 1.36M 1.36M 221K 492K 600K
Change in Working Capital
-21.48M -64.69M -44.14M -56.63M -57.91M -41.13M -57.84M -66.5M -25.59M -53.77M -30.89M -32.05M -27.87M -23.68M -2.38M -30.26M -47.97M
Operating Cash Flow
-145.55M -192.59M -242.15M -333M -415.4M -436.85M -479.32M -504.73M -492.51M -502.28M -394.99M -360.69M -305.6M -298.65M -309.34M 408.58M 370.58M
Capital Expenditures
-5.36M -4.63M -8.37M -14.6M -14.58M -16.06M -12.87M -10.35M -10.35M -8.92M -266.85M -264.12M -262.22M -261.24M -2.52M -1.53M -1.81M
Cash Acquisitions
n/a n/a -83.44M -80.11M -114.73M -290.1M -206.66M -210M -175.38M n/a -35.38M -35.38M -35.38M -35.38M n/a n/a n/a
Purchase of Investments
-1.05B -966.43M -874.32M -914.23M -833.65M -766.36M -879.76M -857.54M -582.64M -489.7M -399.2M -312.74M -612.31M -655.45M -687.36M -1.12B -913.27M
Sales Maturities Of Investments
995.4M 923.56M 880.25M 886.85M 1.03B 1.06B 1.03B 887.51M 657.62M 349.37M 223.12M 369.95M 475.38M 690.83M 735.44M 632.81M 553.16M
Other Investing Acitivies
n/a 78.23M 161.68M 158.34M 192.96M 290.1M 206.66M 209.71M 254.71M 39.4M 74.78M 180.14M -14M 158.31M 48.08M -487.12M -360.11M
Investing Cash Flow
-59.55M -47.5M -2.44M -41.98M 178.38M 274.04M 141.99M 19.34M 64.34M -149.54M -443.21M -206.9M -399.15M -225.86M 45.56M -488.65M -361.91M
Debt Repayment
147.34M 146.97M 146.4M 244.37M 97.56M 97.93M 97.96M -11K -11K -11K n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
68M 77.2M 83.55M 65.6M 39.69M 21.29M 8.23M 388.36M 560.56M 561.82M 577.25M 207.61M 44.97M 50.72M 58.44M 52.55M 40.67M
Financial Cash Flow
215.34M 273.11M 278.88M 358.9M 186.19M 119.22M 106.19M 388.35M 560.55M 561.81M 577.25M 207.61M 44.97M 50.72M 252.88M 326.3M 314.62M
Net Cash Flow
20.77M 42.35M 44.89M -17.41M -51.91M -43.92M -230.96M -96.69M 132.56M -90.22M -262.14M -360.92M -660.77M -474.69M -11.63M 245.64M 322.8M
Free Cash Flow
-150.91M -197.22M -250.52M -347.59M -429.98M -452.91M -492.19M -515.08M -502.86M -511.2M -661.83M -624.81M -567.82M -559.89M -311.86M 407.06M 368.78M